These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1853 related articles for article (PubMed ID: 16595783)
1. Gene expression profiling of primary cutaneous melanoma and clinical outcome. Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A; J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783 [TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of primary cutaneous melanoma. Winnepenninckx V; Van den Oord JJ Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873 [TBL] [Abstract][Full Text] [Related]
3. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
4. Novel role for RGS1 in melanoma progression. Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492 [TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692 [TBL] [Abstract][Full Text] [Related]
6. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007 [TBL] [Abstract][Full Text] [Related]
7. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379 [TBL] [Abstract][Full Text] [Related]
9. Predicting clinical outcome through molecular profiling in stage III melanoma. John T; Black MA; Toro TT; Leader D; Gedye CA; Davis ID; Guilford PJ; Cebon JS Clin Cancer Res; 2008 Aug; 14(16):5173-80. PubMed ID: 18698035 [TBL] [Abstract][Full Text] [Related]
10. PUMA expression is significantly reduced in human cutaneous melanomas. Karst AM; Dai DL; Martinka M; Li G Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057 [TBL] [Abstract][Full Text] [Related]
11. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors. Winnepenninckx V; van den Oord JJ Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928 [TBL] [Abstract][Full Text] [Related]
13. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma. Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma. Rangel J; Torabian S; Shaikh L; Nosrati M; Baehner FL; Haqq C; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M J Clin Oncol; 2006 Oct; 24(28):4565-9. PubMed ID: 17008696 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer. Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in 1,521 melanoma patients with distant metastases. Barth A; Wanek LA; Morton DL J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677 [TBL] [Abstract][Full Text] [Related]
17. Melanoma gene expression and clinical course. Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients. van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma. Wang Y; Dai DL; Martinka M; Li G Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537 [TBL] [Abstract][Full Text] [Related]
20. NBS1 expression as a prognostic marker in uveal melanoma. Ehlers JP; Harbour JW Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]